The Column Group

The Column Group Overview

Investor Type Hedge Fund
Status Active
Professionals 9
Professionals
Investments 75
Portfolio 22
Exits 18
Exits

The Column Group General Information

Description

Founded in 2007, The Column Group is a venture capital firm headquartered in San Francisco, California. The firm prefers to invest in early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics.

Contact Information

Year Founded
2007
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
  • 1700 Owens Street
  • Suite 500
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

The Column Group Investments (75)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Accent Therapeutics 23-Apr-2020 Early Stage VC 0000 Biotechnology Startup 00000000 00000 00.0
00000000 25-Mar-2020 00000 00000 00000 Biotechnology Startup 0000000 0000000 00.0
000000 000000 17-Mar-2020 00000 00000 0000 Drug Discovery Generating Revenue 00000 0000000000
00000 12-Mar-2020 00000 00000 00000 Drug Discovery Generating Revenue 0000000 0000000 00.0
00 000000000000000 05-Nov-2019 00000 00000 0000 Drug Discovery Startup 0000000 0000000 00.0
000000 00000000000 03-Oct-2019 00000 00000 0000 Biotechnology Pre-Clinical Trials 00000 0000000 00.0
0000 0000000000000 08-Aug-2019 00000 00000 0000 Drug Discovery Generating Revenue 00000 0000000000
0000000000 0000000 09-Jul-2019 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable 00000000 00000 00.0
RAPT Therapeutics 18-Jun-2019 Later Stage VC 0000 Drug Discovery Clinical Trials - General 00000 0000000 00.0
eFFECTOR Therapeutics 13-May-2019 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 1 00000000 00000 00.0
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

The Column Group Exits (18)

To view The Column Group‘s complete exit history, request access >>
Company Name Exit Date Exit Type Exit Size
Oric Pharmaceuticals 24-Apr-2020 IPO 00000
0000000000 0000000 13-Feb-2020 000 00000
0000 000000000000 07-Feb-2020 000000 0000000000 0000
0000 000000000000 01-Nov-2019 000 0000
0000000 0000000000 16-Jul-2019 000000000000000000 00.000
0000000 0000000000 11-Jul-2019 000000000000000000 00.000
000 00000000000000 04-Apr-2019 000 00000
000000 000000 02-Apr-2019 000000000000000000 00000
Gritstone Oncology 28-Sep-2018 IPO 00000
Constellation Pharmaceuticals 19-Jul-2018 IPO 0000

The Column Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore The Column Group‘s full profile, request access.

Request a free trial

The Column Group Team (26)

Name Title Deals Funds Boards Office
James Evangelista Chief Financial Officer San Francisco, CA
Peter Svennilson Co-Founder & Managing Partner 00 0 0 San Francisco, CA
David Goeddel Ph.D Managing Partner 00 0 0 San Francisco, CA
Robert Tjian Ph.D Science Partner & Co-Founder 0 0 0 San Francisco, CA
JeenJoo Kang Ph.D Partner 0 San Francisco, CA

7 Former Team Members

The Column Group Co-Investors (103)

To view The Column Group‘s complete co-investor history, request access >>
Name With Exits Lead Partner Series Industry
Casdin Capital 6 0 Series chart Industry bar
EcoR1 Capital 0 0 0 Series chart Industry bar
GV 0 0 Series chart Industry bar
Topspin Partners 0 0 0 Series chart Industry bar
Nextech Invest 0 0 0 Series chart Industry bar